TrialStudy to Investigate Etokimab (ANB020) Activity in Adult Participants With Peanut Allergy
Trial details
- Registry ID
- NCT02920021
- Phase
- Phase 2
Drug research
Etokimab
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
Also recorded as ANB020
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Peanut AllergyNCT02920021 | ANAB | Phase 2 | Completed | 2018-03-30Actual |
| Proof of Concept Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Severe Eosinophilic AsthmaNCT03469934 | ANAB | Phase 2 | Completed | 2018-10-30Actual |
Proof of Concept Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Severe Eosinophilic Asthma
Trial details
- Registry ID
- NCT03469934
- Phase
- Phase 2
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |